Miltefosine (trade names Impavido and Miltex) is a broad-spectrum phospholipid antimicrobial drug.
Lamivudine/zidovudine (trade name Combivir) is a medication used to treat HIV/AIDS.
Stavudine (d4T), sold under the brand name Zerit among others, is an antiretroviral medication used to prevent and treat HIV/AIDS.
Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS.
Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS.
Tenofovir alafenamide (INN/USAN, formerly GS-7340) is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir.
Tenofovir disoproxil/emtricitabine (trade name Truvada) is a fixed-dose combination of two antiretroviral drugs used for the treatment of HIV/AIDS.
Abacavir/lamivudine/zidovudine (INNs, trade name Trizivir) is a pharmaceutical treatment for HIV infection.
Elvitegravir/cobicistat/emtricitabine/tenofovir (brand name Stribild), also known as the Quad pill, is a fixed dose combination drug for the treatment of HIV/AIDS.
Emtricitabine/rilpivirine/tenofovir (trade names Complera, Eviplera) is a fixed dose combination of antiretroviral drugs for the treatment of HIV.
Amprenavir (original brand name Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection.
Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor under development by Merck & Co.
Calanolide A is an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) first acquired from the Calophyllum lanigerum, variety austrocoriaceum, trees in the Malaysian state of Sarawak by botanist John Burley in 1987.
Globoidnan A is a lignan found in Eucalyptus globoidea, a tree native to Australia.
5-Bromouridine (BrUrd) is a uridine derivative with a bromo substituent at the fifth carbon.
Foscarnet is the conjugate base of the chemical compound with the formula HO2CPO3H2.
BIT225 is an experimental drug candidate under development by Biotron Limited for use in the treatment of both HIV and hepatitis C infection.
BMS-955176 is an experimental second generation HIV maturation inhibitor under development by Bristol-Myers Squibb for use in the treatment of HIV infection.